| Genzyme and TJAB Form Partnership ChinaBio Today submits: Genzyme Corporation (NSDQ: GENZ) has established a strategic partnership with Tianjin International Joint Academy of Biotechnology and Medicine (TJAB), holding a formal signing ceremony earlier this week. The partnership will work toward bringing Genzyme’s products, many of which treat rare diseases, to China. The partnership was tasked with pursuing application and translational research, preclinical and clinical studies, diagnostic testing and therapy, as well as doctoral and postdoctoral education training.Complete Story » seekingalpha.com |
Cord Blood America Moving to Close Acquisition of BioCells, Inc., One of South America's Largest Stem Cell Companies (PR Newswire) Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life-saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, today announced that all preliminary due diligence is now complete for the acquisition of controlling interest in BioCells, Inc. us.rd.yahoo.com |
Fertility's New Legal Front Advances in reproductive technology ago are wreaking havoc on a corner of the Social Security system—survivor benefits for children whose parents have died before conception. online.wsj.com |
Nestlé Renews Health Push Nestlé will invest roughly $500 million over ten years to produce more food and drink products with health benefits, a high-margin segment that has proved controversial with regulators and consumers. online.wsj.com |
Depomed: Long-Term Winner Holding Strong M.E. Garza submits: By Patrick Crutcher Shares of Depomed Inc.(NASDAQ: DEPO) have steadily climbed up more than 20% over the past month. We continue to believe that DEPO is one of the strongest biotechnology companies for their marketcap and that shares have considerable upside over the next 4-6 months.Complete Story » seekingalpha.com |